基于蛋白质结构预测的胰岛素样生长因子-1的制备及活性分析
作者:
基金项目:

江汉大学研究生科研创新基金项目(20HG005)


Preparation and activity evaluation of insulin-like growth factor 1 based on protein structure prediction
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [26]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    为了更经济高效地制备胰岛素样生长因子-1(insulin-like growth factor-1,IGF-1),本研究采用计算机模拟技术对3种IGF-1融合蛋白进行蛋白质结构预测与分子对接,筛选出酶切最适配的IGF-1融合蛋白表达形式。利用基因工程技术构建并鉴定了IGF-1融合蛋白原核表达载体,并转化大肠杆菌Origami B (DE3)菌株,获得重组子;经异丙基-β-D-硫代吡喃半乳糖苷(isopropyl-β-D-1-thiogalactopyranoside,IPTG)诱导表达后,对菌体的破菌上清进行亲和层析、脱盐、凝血酶酶切及酶切产物亲和层析纯化得到目的蛋白;通过3T3细胞增殖法建立活性评价体系并对获得的IGF-1进行活性测定。结果显示,构建的IGF-1融合蛋白原核表达载体序列正确,获得的重组子在25℃、0.05 mmol/L IPTG诱导16 h时融合蛋白为可溶性表达,经初步纯化、凝血酶酶切、再次纯化后可获得纯度大于90%的IGF-1目的蛋白,在建立的活性评价体系下测得制备的IGF-1比活为2.47×105 U/mg,与市售标准品接近。本研究建立了一条用于制备IGF-1的完整工艺路线,为IGF-1药物的研制及工业化生产奠定基础。

    Abstract:

    In order to prepare insulin-like growth factor 1 (IGF-1) more economically and efficiently, the structure prediction and molecular docking of three IGF-1 fusion proteins were performed by computer simulation. The most suitable expression form of IGF-1 fusion protein was screened out. A prokaryotic expression vector of IGF-1 fusion protein was constructed and transformed into Escherichia coli Origami B(DE3) strain to obtain the recombinant strain. After induction with IPTG, the target protein was purified from the soluble fractions of the bacteria cell lysate by affinity chromatography, desalination, thrombin digestion and affinity chromatography of the enzyme digested products. An activity evaluation system was established by 3T3 cell proliferation method and the activity of the obtained IGF-1 was measured. The results showed that the sequence of the IGF-1 fusion protein prokaryotic expression vector was correct and the fusion protein was soluble upon 0.05 mmol/L IPTG induction at 25℃ for 16 h. After preliminary purification, thrombin digestion and re-purification, IGF-1 target protein with purity over 90% was obtained. Using the established activity evaluation system, the specific activity of IGF-1 was 2.47×105 U/mg, which was close to the standard product available at the market. The preparation technology of IGF-1 developed in this study may facilitate the development and industrial production of IGF-1 drugs.

    参考文献
    [1] Mueller PL, Pritchett CE, Wiechman TN, et al. Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain. Brain Res Bull, 2018, 143:27-35.
    [2] 谢倩, 李佳楠. 胰岛素样生长因子-1衍生物的研究进展. 江汉大学学报(自然科学版), 2019, 47(6):555-562. Xie Q, Li JN. Research progress of insulin-like growth factor-1 derivatives. J Jianghan Univ (Nat Sci Ed), 2019, 47(6):555-562(in Chinese).
    [3] Pagani S, Bozzola E, Acquafredda G, et al. GH-IGF-1 axis in children with cystic fibrosis. Clin Med Res, 2019, 17(3/4):82-89.
    [4] Palmieri VV, Lonero A, Bocchini S, et al. Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment. Growth Horm IGF Res, 2019, 48/49:9-15.
    [5] Bianchi A, Giampietro A, Tartaglione L, et al. Short-and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency:role of GH receptor polymorphism. J Neuroendocrinol, 2019, 31(4):e12692.
    [6] Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentation of growth hormone-a new inborn error of metabolism? Isr J Med Sci, 1966, 2(2):152-155.
    [7] Laron Z, Werner H. Laron syndrome-a historical perspective. Rev Endocr Metab Disord, 2021, 22(1):31-41.
    [8] Castilla-Cortazar I, De Ita JR, Aguirre GA, et al. Fanconi anemia and laron syndrome. Am J Med Sci, 2017, 353(5):425-432.
    [9] Sádaba MC, Martín-Estal I, Puche JE, et al. Insulin-like growth factor 1(IGF-1) therapy:mitochondrial dysfunction and diseases. Biochim Biophys Acta, 2016, 1862(7):1267-1278.
    [10] Bang P, Woelfle J, Perrot V, et al. Effectiveness and safety of rhIGF therapy in patients with or without laron syndrome. Eur J Endocrinol, 2021, 184(2):267-276.
    [11] Lazea C, Grigorescu P, Legendre M, et al. Novel compound heterozygous mutations of growth hormone receptor gene in two Romanian siblings with laron syndrome. Eur J Hum Genet, 2019, 26:860-871.
    [12] Obradovic M, Zafirovic S, Soskic S, et al. Effects of IGF-1 on the cardiovascular system. Curr Pharm Des, 2019, 25(35):3715-3725.
    [13] Iglesias P, Villabona C, Díez JJ. Effects of cabergoline therapy on serum IGF-1 concentrations in prolactinoma patients. Pituitary, 2020, 23(2):200-202.
    [14] Pearce R, Zhang Y. Deep learning techniques have significantly impacted protein structure prediction and protein design. Curr Opin Struct Biol, 2021, 68:194-207.
    [15] Geng H, Chen FF, Ye J, et al. Applications of molecular dynamics simulation in structure prediction of peptides and proteins. Comput Struct Biotechnol J, 2019, 17:1162-1170.
    [16] Nagano K, Akpan A, Warnasuriya G, et al. Functional proteomic analysis of long-term growth factor stimulation and receptor tyrosine kinase coactivation in Swiss 3T3 fibroblasts. Mol Cell Proteom, 2012, 11(12):1690-1708.
    [17] Li Y, Zhang XL, Song SM, et al. Baicalein inhibits proliferation and collagen synthesis of mice fibroblast cell line NIH/3T3 by regulation of miR-9/insulin-like growth factor-1 axis. Artif Cells Nanomed Biotechnol, 2019, 47(1):3202-3211.
    [18] Erol N, Yıldız M, Güven A, et al. Cardiac examination in children with laron syndrome undergoing mecasermin therapy. J Pediatr Endocrinol Metab, 2018, 31(6):675-679.
    [19] Liang Y, Guo H, Liu B, et al. Genomic structure and characterization of growth hormone receptors from golden pompano Trachinotus ovatus and their expression regulation by feed types. Fish Physiol Biochem, 2019, 45(6):1845-1865.
    [20] Racine HL, Serrat MA. The actions of IGF-1 in the growth plate and its role in postnatal bone elongation. Curr Osteoporos Rep, 2020, 18(3):210-227.
    [21] O'Leary HM, Kaufmann WE, Barnes KV, et al. Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol, 2018, 5(3):323-332.
    [22] 刘侃. 重组人胰岛素样生长因子-1在大肠杆菌中的高效表达及体外复性摸索[D]. 广州:暨南大学, 2006. Liu K. Overexpression of recombinant human insulin-like growth factor-1 in E. coli and in vitro refolding[D]. Guangzhou:Jinan University, 2006(in Chinese).
    [23] 万爱妮, 徐栋生, 蔡燕飞, 等. 硫氧还蛋白促进人胰岛素样生长因子-1在大肠杆菌中高效可溶表达. 食品与生物技术学报, 2019, 38(4):50-57. Wan AN, Xu DS, Cai YS, et al. Thioredoxin increases the efficient and soluble expression of insulin-like growth factor-1 in E. coli. J Food Sci Biotechnol, 2019, 38(4):50-57(in Chinese).
    [24] Franzini M, Bramanti E, Ottaviano V, et al. A high performance gel filtration chromatography method for γ-glutamyltransferase fraction analysis. Anal Biochem, 2008, 374(1):1-7.
    [25] Xin XL, Yang Y, Zhong J, et al. Preparative isolation and purification of isobenzofuranone derivatives and saponins from seeds of Nigella glandulifera Freyn by high-speed counter-current chromatography combined with gel filtration. J Chromatogr A, 2009, 1216(19):4258-4262.
    [26] Yue DR, Yang L, Liu SX, et al. A continuous procedure based on column chromatography to purify anthocyanins from Schisandra chinensis by a macroporous resin plus gel filtration chromatography. Molecules, 2016, 21(2):1-14
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

谢倩,李冠霖,李颖,李佳楠. 基于蛋白质结构预测的胰岛素样生长因子-1的制备及活性分析[J]. 生物工程学报, 2022, 38(6): 2259-2268

复制
分享
文章指标
  • 点击次数:354
  • 下载次数: 1550
  • HTML阅读次数: 1662
  • 引用次数: 0
历史
  • 收稿日期:2021-09-17
  • 在线发布日期: 2022-06-28
  • 出版日期: 2022-06-25
文章二维码
您是第6454311位访问者
生物工程学报 ® 2025 版权所有

通信地址:中国科学院微生物研究所    邮编:100101

电话:010-64807509   E-mail:cjb@im.ac.cn

技术支持:北京勤云科技发展有限公司